医药研发行业薪酬福利调查报告(PPT 95页)

Engage Talent, Improve Productivity
Overview of Hewitt R&D Center Study
Hewitt 2010 CPRDS Participant List – Totaling 31
Today’s Content
Marco-economic Situation in the World
China Market Movement
China’s Source of Growth is Shifting
China Beating Japan in term of Share of Total Global R&D Spending
The Government is the Main Source of China R&D Investment
Emerging Economics Driving Global R&D Growth
Slowing Global Pharma Growth with Parmerging Growth Outpacing the Rest
40% Among Global Innovation Top 20 Companies are from Pharma Industry
Increasing Expense in Pharma R&D but Decreasing Output
The Road to Positive R&D Returns
All Major Big Pharmas Have Stepped up their Investments in China in the Past One or Two Years
CRO Benefits from Pharma Moving Up the Value Chain
More Talent Demands from Clinical Development with Overall Big Target Headcount Increase
R&D Employee Headcount Keeping Increasing
China Year-on-Year Employee Turnover
R&D Talent Turnover Keeping High, Similar to 2009
R&D Talent Turnover Reason Analysis
Employee Engagement can Improve Organization Performance
Six Categories Drive Employee Engagement
External Competitiveness: Salary Increase China National Salary Increase (excluding promotion)
Higher R&D Salary Increase
Pharma R&D Salary IncreaseFor Local and Returnee
Pharma R&D Salary IncreaseFor China Hired Foreigner
Pharma R&D Pay Level Analysis – Market Median
Cash Comparison by Employee Category
Cash Comparison by R&D Category
Fresh GraduateStarting Salary Analysis
Supplemental Benefits Market Prevalence
Supplemental BenefitsReturnee and Local Hired Foreigner
Recognition Best PracticesHewitt POV
Hewitt Framework on Performance Management
..............................